Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
A phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy in patients with advanced biliary tract cancer: BilT-02.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 29, 2025
BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer.
Journal: Med (New York, N.Y.)
Published: April 05, 2024
PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma.
Journal: The oncologist
Published: February 26, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2024
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 19, 2023
Genomics driven precision oncology in advanced biliary tract cancer improves survival.
Journal: Neoplasia (New York, N.Y.)
Published: May 11, 2023
Reply to "Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?"
Journal: Cancer
Published: January 24, 2023
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 11, 2023
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 19, 2022
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.
Journal: The oncologist
Published: August 29, 2022
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.
Journal: Frontiers in oncology
Published: June 07, 2022
Last Updated: 09/26/2026